Klifovet: Animal Health medicines and Nutrition products development.- Oversee the process of our customer products development, from the idea to marketing authorization (pre-clinical and clinical development, regulatory and business strategy) and Pharmaceutical Sciences activities/proof of concept (formulation, analytical chemistry, process engineering) in relation with CRO/CDMOs partners.- Global Project Management - Alliance management

Reporting directly to the CEO and responsible for global R&D, MSaT and business development/R&D commercial. I provide leadership to the pharmaceutical R&D excellence center (50 FTEs in Orleans) and 3 Group Functions (business development, sales excellence, and R&D commercial)In this role I provide strategic direction and work closely with my team to build and deploy that strategy in order to contribute in a meaningful way to the overall Corporate Objectives.

Worldwide responsibility for developing Life Cycle Management (LCM) products for the group and implementing new Technologies and processes (manufacturing and/or process flows)As part of this newly created function at Vetoquinol (Director MSaT-Manufacturing Sciences and technologies), built team (12 direct reports, six sites, five countries) composed of 45 FTEs, Pharmaceutical development experts (laboratories), process engineers (production sites) and global project management and scientific expertise: established vision/mission, communication and animation, process flows, priorities management, KPI indicators and mutual support through weekly virtual and face-to-face meetings.• Established an Incremental Innovation platform with operational functions, marketing and commercial allowing existing portfolio growth (+ 30% over 4 years) and product differentiation (reboot of Flexadin range to #1 market leader with addition of softchews• Coordinated with manufacturing sites Directors, R&D director and teams in planning, management and execution of Technology Transfer programs (4 global programs completed including Bio-products), investigation studies (product robustness and safety), business integration post acquisition (Bioniche product range) and industrialization of new products (In-House R&D).• Industrial supervision of the production site and operation of Vetoquinol in Tarare (France) (40 FTEs)• Supervised the global external manufacturing operations and contracts with CDMO for the entire group product portfolio• Continuous improvement programs and initiatives as part of the global Vetoquinol Operational Excellence.

Responsible for providing scientific and technical oversight for global product developments, innovation integration, technology transfer and global R&D strategy. Oversaw global R&D department with responsibility ~150 FTEs (8 direct reports). Led team over 5 sites in France (including the excellence development center of 110 FTEs), Italy, Poland, Canada and Brazil running R&D development activities of innovative pharmaceutical veterinary drugs (EMA, FDA). • Orchestrated worldwide Drug new developments, from innovation (conception), drug prototypes, clinical development to regulatory preparation and regulatory submission.• Drove the implementation of the new R&D center in the USA (Dallas Tx) in close relation with CVM (FDA) allowing the dynamic submission of clinical studies protocols (R&D candidates) and/or regulatory dossiers • Engaged the Development division towards Operational Excellence and create a culture centered on execution (one blockbuster every two years and average time reduction of the development program by 6 Months)Director Board leader of the Scientific Committee for Vetoquinol Corporation

Responsible for providing scientific oversight of new development projects and for assessing new technologies • Supervised innovation activities and partnerships with scientific peers from University, public research institutes and identified pharmaceutical and biotechnology companies.• Led and contributed to the Operational Excellence Lean implementation & to the process improvement initiatives (Black Belt training in Lean six sigme, Houston (TX))o Created and implemented a new R&D business model: licensing of in-house developed products for preferred pharma partners

Led team of 25 Scientifics (5 direct reports) in CMC (formulation, analytical chemistry, process development and industrialization (tech transfer)) for customer’s pharma product development dossier.• Ran studies in pre-formulation, formulation, prototype selection, clinical manufacturing, process qualification and process validation of regulatory dossiers (EMA, FDA). • Coordinated the FDA Pre-Approval Inspections for US regulatory product submission• Consolidated CMC activities as global R&D function: transformed individual sub-units into cohesive, high-performing team, project management driven, in direct interface with Cardinal productions sites with efficiency gains. • Director Board member of the French subsidiaries

Manage the global manufacturing Technology Transfer of US Product (FDA) between Worldwide subsidiaries.• Leader of the strategic planning management for Cardinal process design development division.• Subject matter expert for Development Regulatory, Process Compliance & Drug Delivery Sciences for Europe

Pharmaceutical development of novel genomic therapy: biosynthetic RNA-targeted therapeutics (medicine drugs).• Organization of the biological / pharmaco-kinetic evaluation and the pre-clinical study.